Trovagene Presents Data Showing Sensitivity of Triple Negative Breast Cancer (TNBC) Cell Lines to PCM-075 and Synergy with Zytiga® at San Antonio Breast Cancer Symposium (SABCS)
wardsauto.com -

SAN DIEGO, Dec. 7, 2017 /PRNewswire/ -- Trovagene, Inc.

read more

Loading...

Related Articles